Although health care services in developing countries are generally recognized to be poor, the quality of STI care is especially poor for FSWs, a stigmatized group which faces discrimination in many societies.
In case of the patients who were most newly diagnosed with gastric cancer or gastric cancer with distant metastasis, the mean 5-year survival rate is recognized to be poor at less than 10% [ 3].
In general, prognosis for adults diagnosed with AML was recognized to be poor, but there was considerable heterogeneity by subtype with almost three-quarters of those diagnosed with acute promyelocytic leukaemia t(15 17)(q11 1211–12) surviving beyond 4 years.
Likewise, these two factors have been previously recognized to be associated with poor health-related quality of life in people living with several musculoskeletal conditions, including IRDs, osteoarthritis, low back pain and soft tissue disorders, as reported in an Italian population [ 29].
Several vaccines are recognized to be less immunogenic in poor populations [ 7, 8, 10, 62- 66] requiring an increase in the dose or number of doses administered to achieve adequate vaccine immunity [ 7, 67].
The development of genomic instability leading to the evolution of aneuploid cell lineages is a hallmark of many cancers and was early recognized to be associated with a poor prognosis [ 7, 26, 27, 34].
Risk factors for poor bowel preparation are recognized to be independent of the type of bowel preparation method used.
Instead of trying to protect the wealthy, Dr. Berwick wrote, the British recognized that "sick people tend to be poorer and that poor people tend to be sicker, and that any health care funding plan that is just must redistribute wealth".
He praised Britain as "recognizing that sick people tend to be poorer and that poor people tend to be sicker, and that any health care funding plan that is just, equitable, civilized and humane must — must — redistribute wealth from the richer among us to the poorer and less fortunate".
Some of the recognized challenges are poor engraftment of implanted cells and, in the case of human cardiomyocytes, functional immaturity and lack of electrical integration, leading to limited contribution to the heart's contractile activity and increased arrhythmogenic risks.
The vertical component has been recognized to have a poorer quality and has seldom been subjected to detailed examinations.
